Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex

Abroad (travel likely)RecruitingPHASE3

Conditions

Tuberous Sclerosis Complex

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Medical University of Lodz, Lodz, Poland
Contact: Study coordinator (Wojciech Mlynarski) · wojciech.mlynarski@umed.lodz.pl · +48 42 617-77-91
Children's Memorial Health Institute, Neurology and Epileptology, Warsaw, Poland
Contact: Study coordinator (Katarzyna Kotulska-Jozwiak) · k.kotulska@ipczd.pl · +48 22 8157404
Contact: Study coordinator (Monika Szkop) · m.szkop@ipczd.pl · +48 22 815 74 04

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

Tuberous Sclerosis Complex (TSC)

Abroad (travel likely)RecruitingPHASE3

Madrid, Spain

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Tuberous Sclerosis Complex · Epilepsy

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Los Angeles, United States

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

Neurodevelopmental Disorders · Autism · Autism Spectrum Disorder

Abroad (travel likely)RecruitingPHASE2

Calgary, Canada · Edmonton, Canada

Role of Genetic Factors in the Development of Lung Disease

Cystic Fibrosis · Pulmonary Fibrosis · Tuberous Sclerosis

Abroad (travel likely)Recruiting

Bethesda, United States · Bethesda, United States